|Front Page Previous Story Next Story||
2003 Medicine for the Public Lectures Set
The 2003 Medicine for the Public lecture series, now in its 27th year, features NIH physician-researchers working on the forefront of medical discovery. The series helps people understand the latest developments in medicine with an emphasis on topics of current relevance. Sponsored by the Clinical Center, the lectures are held at 7 p.m. on Tuesdays in Masur Auditorium, Bldg. 10. All lectures are free and open to the public.
Sept. 16 "Alzheimer's Disease: Advances and Hope," Dr. Trey Sunderland, chief, Geriatric Psychiatry Branch, NIMH.
Despite many recent advances in the understanding of Alzheimer's disease, its diagnosis is still based on vague clinical criteria and confirmed only by biopsy or autopsy. Sunderland will describe progress to date of a comprehensive study to examine the spinal fluid of Alzheimer's patients during the course of their illness compared to healthy patients.
Sept. 23 "Preparing for SARS, or Smallpox, or Whatever Comes Next: Responding to Emerging Infectious Diseases and Bioterrorism Threats," Dr. David Henderson, deputy director for clinical care, Clinical Center.
The world has recently seen an emergence or reemergence of infectious diseases such as smallpox, SARS, West Nile virus, and monkeypox. Henderson will discuss these and how the Clinical Center has responded to new diseases in the past.
Sept. 30 "Sickle Cell Anemia: Moving from Pain to Cure," Dr. Mark Gladwin, senior investigator, section chief, sickle cell/nitric oxide therapeutics section, CC critical care medicine department.
Sickle cell disease is one of the most common inherited blood disorders in the U.S. Understanding the disease and its warning signs aids researchers working to unravel the mysteries of sickle cell. Gladwin will cover those topics and related ongoing clinical research.
Oct. 7 "Stem Cell Transplantation: Promise in Cancer Treatments and Blood Disorders," Dr. Michael Bishop, investigator and clinical head, Experimental Transplantation and Immunology Branch, NCI.
Bone marrow transplantation has been in clinical use for more than 30 years. Today, it is more commonly referred to as stem cell transplantation, as stem cells can be obtained from several sources other than bone marrow. Bishop will discuss research efforts that focus on increasing application of stem cell transplantation to a broader patient population.
Oct. 21 "When Too Much Iron Is Bad: Hemochromatosis, the Silent Blood Disease," Dr. Susan Leitman, acting chief of transfusion medicine, CC.
Too much iron in the blood can cause health problems. Carrying potentially serious effects is a blood disorder called hemochromatosis. It can cause liver damage and premature arthritis. This easily detectable and treatable disorder, often called the silent blood disease, is the focus of Leitman's presentation.
Oct. 28 "Complementary and Alternative Medicine: From Promises to Proof," Dr. Stephen Straus, director, National Center for Complementary and Alternative Medicine.
Arthritis, depression, menopause, cancer for millions of Americans, these and other health concerns are not being adequately addressed through conventional medicine. Many are turning to other approaches. Straus will discuss research on which complementary and alternative medicine practices work and whether they are safe.
For more information on the MFP series, call 496-2563, or visit http://www.cc.nih.gov/ccc/mfp/current/index.html.
Up to Top